Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Stada Arzneimittel AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Stada Arzneimittel AG, Medical Devices Deals, 2012 to YTD 2018 12
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deal Details 15
Asset Purchase 15
Stada Arzneimittel Acquires Nizoral from Janssen Pharma 15
STADA Arzneimittel Acquires AndroDoz and NeroDoz from OOO PharmEnergy for USD7.9 Million 16
Thornton & Ross Acquires Rights for Flexitol from LaCorium Health for USD17 Million 17
Nizhpharm Completes Acquisition Of Aqualor Product Portfolio For US$178 Million 18
STADA Arzneimittel Completes Acquisition Of Generics Business From Spirig Pharma For US$108 Million 19
STADA Completes Acquisition Of Branded Product Portfolio In Central Europe From Grunenthal For US$230 Million 20
Private Equity 22
Bristol-Myers Squibb May Sell UPSA to BC Partners, CVC Capital, PAI Partners and STADA for USD1.16 Billion 22
Ardian May Sell Riemser Pharma for USD494.3 Million 24
Bain Capital and Cinven Partners to Acquire Stada Arzneimittel 26
Bain Capital Private Equity and Cinven Partners Renew the Terms to Acquire Stada Arzneimittel 28
Partnerships 30
Xbrane Biopharma and STADA Arzneimittel Enter into Co-Development Agreement 30
Enzymatica Enters into Distribution Agreement with STADA for ColdZyme 31
Theratechnologies Enters into Commercialization Agreement with BL&H 32
Stada Arzneimittel to Form Joint Venture with Hetero Drugs 33
Claris Lifesciences Enters into Distribution Agreement with Stada Arzneimittel 34
Licensing Agreements 35
BL&H Enters into Licensing Agreement with Race Oncology 35
BL&H Enter into Licensing Agreement with MDNA Life Sciences 36
Thornton & Ross Enters into Licensing Agreement with Futura Medical 37
BL&H Enters into Licensing Agreement with Telesta Therapeutics 38
STADA Arzneimittel Enters into Licensing Agreement with Gedeon Richter 39
Stada Arzneimittel to Enter into Licensing Agreement with mAbxience 40
Stada Arzneimittel Enters into Licensing Agreement with Richter-Helm BioTec 41
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 42
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir 44
Equity Offering 45
Telesta Therapeutics Raises USD0.2 Million in Private Placement of Shares 45
Debt Offering 46
Stada Arzneimittel Announces Private Placement of Bonds Due 2022 for USD325.5 46
Stada Arzneimittel Completes Private Placement Of Bonds Due 2018 For US$452 Million 47
Asset Transactions 48
DMN Invest Acquires Two Drug Manufacturing Facilities From Stada Arzneimittel 48
Acquisition 49
Nidda Healthcare to Acquire Stake in Stada Arzneimittel 49
Elliott Management May Acquire Stake in Stada Arzneimittel 50
STADA Arzneimittel to Acquire Laboratorio Vannier for USD13 Million 51
STADA Arzneimittel Acquires SCIOTEC Diagnostic Technologies for USD19.8 Million 52
Stada Arzneimittel Completes Acquisition Of Thornton & Ross, OTC Drug Maker, For US$339 Million 53
Sun Pharma Mulls Acquisition Of Stada Arzneimittel 55
Stada Arzneimittel AG – Key Competitors 56
Stada Arzneimittel AG – Key Employees 57
Stada Arzneimittel AG – Locations And Subsidiaries 58
Head Office 58
Other Locations & Subsidiaries 58
Recent Developments 61
Financial Announcements 61
Aug 09, 2018: STADA’s business development in the first six months of 2018 as expected 61
May 03, 2018: STADA with solid business development in the first quarter of 2018 63
Mar 08, 2018: STADA records positive business development in 2017 65
Nov 09, 2017: STADA shows good business development in the third quarter of 2017 and the first nine months 68
Corporate Communications 70
Sep 03, 2018: Peter Goldschmidt to succeed Claudio Albrecht as STADA’s CEO 70
Apr 16, 2018: Changes in the management team of STADA 71
Feb 01, 2018: Supervisory Board of STADA Arzneimittel appoints Peter Goldschmidt as new Chairman of the Executive Board as of September 1, 2018 72
Feb 01, 2018: Peter Goldschmidt to succeed Claudio Albrecht as CEO on 1 September 2018 73
Jul 04, 2017: STADA Arzneimittel appoints new Chief Executive Officer and Chief Financial Officer – incumbents step down from their positions 74
Apr 24, 2017: Dr. Ralph Grobecker to become Managing Director of STADA’s OTC segment 75
Other Significant Developments 76
Sep 12, 2018: STADA invites the holders of the STADA Bond to participate in the bondholders meeting and to vote in favor of the proposed resolutions 76
Mar 08, 2018: CEO Albrecht to modernize STADA – Biosimilars to focus on oncology, CNS, diabetes and ophthalmology 77
Aug 03, 2017: STADA shows good operational development in first six months of 2017 78
Appendix 81
Methodology 81
About GlobalData 81
Contact Us 81
Disclaimer 81
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Stada Arzneimittel AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Stada Arzneimittel AG, Deals By Therapy Area, 2012 to YTD 2018 10
Stada Arzneimittel AG, Medical Devices Deals, 2012 to YTD 2018 12
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Stada Arzneimittel Acquires Nizoral from Janssen Pharma 15
STADA Arzneimittel Acquires AndroDoz and NeroDoz from OOO PharmEnergy for USD7.9 Million 16
Thornton & Ross Acquires Rights for Flexitol from LaCorium Health for USD17 Million 17
Nizhpharm Completes Acquisition Of Aqualor Product Portfolio For US$178 Million 18
STADA Arzneimittel Completes Acquisition Of Generics Business From Spirig Pharma For US$108 Million 19
STADA Completes Acquisition Of Branded Product Portfolio In Central Europe From Grunenthal For US$230 Million 20
Bristol-Myers Squibb May Sell UPSA to BC Partners, CVC Capital, PAI Partners and STADA for USD1.16 Billion 22
Ardian May Sell Riemser Pharma for USD494.3 Million 24
Bain Capital and Cinven Partners to Acquire Stada Arzneimittel 26
Bain Capital Private Equity and Cinven Partners Renew the Terms to Acquire Stada Arzneimittel 28
Xbrane Biopharma and STADA Arzneimittel Enter into Co-Development Agreement 30
Enzymatica Enters into Distribution Agreement with STADA for ColdZyme 31
Theratechnologies Enters into Commercialization Agreement with BL&H 32
Stada Arzneimittel to Form Joint Venture with Hetero Drugs 33
Claris Lifesciences Enters into Distribution Agreement with Stada Arzneimittel 34
BL&H Enters into Licensing Agreement with Race Oncology 35
BL&H Enter into Licensing Agreement with MDNA Life Sciences 36
Thornton & Ross Enters into Licensing Agreement with Futura Medical 37
BL&H Enters into Licensing Agreement with Telesta Therapeutics 38
STADA Arzneimittel Enters into Licensing Agreement with Gedeon Richter 39
Stada Arzneimittel to Enter into Licensing Agreement with mAbxience 40
Stada Arzneimittel Enters into Licensing Agreement with Richter-Helm BioTec 41
Stada Arzneimittel Enters Into License Agreement With Apotex For Filgrastim 42
Clinigen Enters Into Licensing Agreement With BL&H For Foscavir 44
Telesta Therapeutics Raises USD0.2 Million in Private Placement of Shares 45
Stada Arzneimittel Announces Private Placement of Bonds Due 2022 for USD325.5 46
Stada Arzneimittel Completes Private Placement Of Bonds Due 2018 For US$452 Million 47
DMN Invest Acquires Two Drug Manufacturing Facilities From Stada Arzneimittel 48
Nidda Healthcare to Acquire Stake in Stada Arzneimittel 49
Elliott Management May Acquire Stake in Stada Arzneimittel 50
STADA Arzneimittel to Acquire Laboratorio Vannier for USD13 Million 51
STADA Arzneimittel Acquires SCIOTEC Diagnostic Technologies for USD19.8 Million 52
Stada Arzneimittel Completes Acquisition Of Thornton & Ross, OTC Drug Maker, For US$339 Million 53
Sun Pharma Mulls Acquisition Of Stada Arzneimittel 55
Stada Arzneimittel AG, Key Competitors 56
Stada Arzneimittel AG, Key Employees 57
Stada Arzneimittel AG, Subsidiaries 58
List of Figures
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Stada Arzneimittel AG, Medical Devices Deals, 2012 to YTD 2018 12